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Abstract
Contrast-enhanced ultrasound (CEUS) is an advanced
approach to in vivo assessment of tumor vascularity
and is being increasingly adopted in clinical oncology.
It is based on 1– to 10 Mm–sized gas microbubbles,
which can cross the capillary beds of the lungs and are
effective echo enhancers. It is known that high cell
density, high transendothelial fluid exchange, and
poorly functioning lymphatic circulation all provoke
solid stress, which compresses vessels and drasti-
cally reduces tumor blood flow. Given their size, we
supposed that the perfusion of microbubbles is
affected by anatomic features of tumor vessels more
than are contrast agents traditionally used in dynamic
contrast-enhanced magnetic resonance imaging
(DCE-MRI). Here, we compared dynamic information
obtained from CEUS and DCE-MRI on two experi-
mental tumor models exhibiting notable differences in
vessel anatomy. We found that tumors with small,
flattened vessels show a much higher resistance to
microbubble perfusion than to MRI contrast agents,
and appear scarcely vascularized at CEUS examina-
tion, despite vessel volume adequate for normal
function. Thus, whereas CEUS alone could induce
incorrect diagnosis when tumors have small or
collapsed vessels, integrated analysis using CEUS
and DCE-MRI allows in vivo identification of tumors
with a vascular profile frequently associated with
malignant phenotypes.
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Introduction
Tumor vascularization is strongly correlated to histologic
grade, and much interest has been devoted to its noninva-
sive investigation in vivo.
Dynamic contrast-enhanced magnetic resonance imag-
ing (DCE-MRI) techniques are widely used in preclinical and
clinical settings [1–3].
Contrast media for ultrasonography (UCAs) have recently
been developed, providing exciting new opportunities for func-
tional ultrasound imaging [4–6]. They are composed of 1– to
10 mm–sizedmicrobubbles, which can cross capillary beds and
are safe and effective echo enhancers. Given their micrometer
size, microbubbles should simulate the dynamics of erythro-
cytes because they are able to flow through macrocirculation
and microcirculation without extravasation from the vascular
network, despite the leakiness of tumor vessels. Some studies
provided preliminary evidence that microbubble-induced en-
hancement could be useful in tumor diagnosis [7–9].
In clinical practice, CEUS-based analysis of tumor vas-
cularization is based on the intensity of contrast agent–
induced signal enhancement. This parameter is assumed to
be proportionate to total vascular volume, but how much it
may be affected by the anatomic and functional characteris-
tics of tumor vessels and their surrounding parenchyma is far
from obvious.
It has been reported that frequently occurring aspects of
tumor anatomy such as high cell density [10], high transendo-
thelial fluid exchange [11,12], and poorly functioning lymphatic
circulation [13–16] all provoke solid stress, which can com-
press vessels and drastically reduce tumor blood flow.
Due to their size, it is reasonable to suppose that the
perfusion of microbubbles could be more affected by tumor
histologic and vascular architecture than are the micromolecu-
lar and even macromolecular contrast agents commonly used
in DCE-MRI. Clarification of this question would be of notable
interest because it would highlight the risk of diagnostic
mistakes in the clinical use of microbubbles. Furthermore,
the integration of CEUS and DCE-MRI technologies would
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make it possible to obtain more information than a generic
vascularity index.
With the aim of investigating how the histologic features of
tumor vessels and the surrounding parenchyma can affect
CEUS- and DCE-MRI–based vascular diagnosis, we com-
pared the application of these technologies to an experi-
mental model of carcinoma and an experimental model of
sarcoma, both provoked by subcutaneous injection of differ-
ent cell lines that had been established from the same
mammary carcinoma model. These two histotypes of tumors
were chosen because they exhibited a different vascular
anatomy, as described below. As the carcinomatoid one,
the sarcomatoid model represents a tumor histotype that
frequently occurs in humans. Sarcomas can be observed in
varied anatomic districts, including the breasts [17–20],
where they are the result of an aberrant stromal reactivity
[21–23] and/or epithelial mesenchymal transition event [24].
Materials and Methods
Animals
This study was carried out on FVB mice, line 233, which
were transgenic for the activated isoform of rat HER-2/neu
oncogene (FVB/neuNT233), purchased from Charles River
Laboratories (Calco, Italy). The mice had been bred under
‘‘pathogen-free’’ conditions inside galvanized cages (four to
six mice per cage) at 20 ± 1jC temperature and 50 ± 1% hu-
midity. The animals were exposed to cycles of 12 hours light/
12 hours dark, and were fed with standard foodstuff (Nossen,
UD, Italy) and water ad libitum. The presence of transgene
was routinely checked by polymerase chain reaction on
tail DNA using primers specific for vector (sense: 5V-AT-
CGGTGATGTCGGCGATAT-3V) and MMTV promoter (anti-
sense: 5V-GTAACACAGGCAGATGTAGG-3V) sequences.
Establishment of Transgenic Mammary Carcinoma
Cell Cultures
Tumors surgically excised from 6-month–old transgenic
mice were minced with scissors and lancet, seeded in
tissue culture flasks in Dulbecco’smodified essential medium
(DMEM) + 20% fetal bovine serum (FBS) (Invitrogen, Carls-
bad, CA, USA), and incubated at 37jC in a humidified 5%
CO2 atmosphere. After the sprouting of cells from tissue
fragments, the cultures were periodically washed briefly
(1–3 minutes) with trypsin–EDTA to detach contaminating
fibroblasts without damage to epithelial areas. After several
washings, 3 to 5 months after plating, the resulting confluent
epithelial monolayer was diluted to as few as 5 cells/ml
and split in a 96-well plate to obtain clones derived from
single cells. The colonies were subsequently subcloned and
the cell lines obtained were established by several subcultur-
ing steps.
Experimental Tumors
A total of 5  105 cells suspended in 0.1 ml of phosphate-
buffered saline (PBS) was subcutaneously injected into the
backs of 5– to 7 week–old female FVB/neuNT233 mice.
Tumor growth was followed and tumor size was measured
weekly using calipers. The animals underwent DCE-MRI and
CEUS when the longest diameter of their tumors reached 10
to 15 mm.
DCE-MRI with Gd-DTPA-Albumin
Six animals that had been subcutaneously injected with
the A17 cell line and six animals injected with the BB1 cell line
underwent DCE-MRI exams using Gd-DTPA-albumin (ob-
tained fromR. Brasch, Contrast Media Laboratory, University
of California, San Francisco, CA) as the contrast agent.
The animals were anesthesized by inhalation of a mix-
ture of air and O2, which contained 0.5% to 1% halothane,
and were placed in a prone position inside a 3.5-cm i.d.
transmitter–receiver birdcage coil. Images were acquired
using a Biospec tomograph (Burker, Karlsruhe, Germany)
equipped with a 4.7-T, 33-cm bore horizontal magnet (Ox-
ford Ltd., Oxford, UK). Coronal spin-echo (SE) and transver-
sal multislice, fast SE T2w (RARE, TE = 70 milliseconds)
images were acquired for tumor localization. Afterward, a
dynamic series of 3D transversal spoiled-gradient echo
(SPGR) images was acquired with the following parameters:
repetition time (TR)/echo time (TE) = 50/3.5 milliseconds, flip
angle (a) = 90j, matrix size = 128 64 32, and field of view
(FOV) = 5  2.5  3 cm3 (corresponding to 0.39  0.39 mm2
in-plane resolution and 0.94 mm slice thickness), The num-
ber of acquisitions (NEX) = 1. The acquisition time for a
single 3D image was 104 seconds; a dynamic scan of
24 images was acquired with 30-second intervals between
each image (total acquisition time, 53 minutes). The con-
trast agent was injected in bolus during the interval be-
tween the first and the second scan. A phantom containing
1 mM Gd-DTPA in saline was inserted in the FOV and used
as an external reference standard to normalize possible
spectrometer drifts during the acquisition [25]. The experi-
mental protocol closely followed that previously described
by Daldrup et al. [25] except that precontrast T1 values were
measured using the IR-SnapShot Flash technique [26].
Data analysis was adapted from references for the spe-
cial case of macromolecular contrast agents. Briefly, the
signal intensity was firstly converted to Gd concentration;
the time dependence of Gd concentration was analyzed
in terms of a two-compartment tissue model composed of
plasma and interstitial water equilibrating pools. Fitting of
the theoretical expression to experimental data provided
quantitative values of transendothelial permeability (kPS)
and fractional plasma volume (fPV) of the tumor tissue.
Images were analyzed on a region of interest (ROI) basis
to obtain the average value of kPS and fPV in the selected
ROI: in each animal, the central five slices of the 3D data
set were analyzed. For each considered slice, ROIs were
manually tracked to cover the tumor. The signal was aver-
aged and analyzed to obtain the mean kPS and fPV values
of the selected slice.
CEUS
All the CEUS examinations were performed on a Technos
(Esaote, Milan, Italy) with harmonic microbubble-specific
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imaging setting at very low acoustic ultrasound pressure
(CnTI, 8 MHz; MI < 0.1; DP 15 kPS). Sulfur hexafluoride in
the form of microbubbles (SonoVue Bracco, Milan, Italy)
was used. A linear array transducer (LA532E 8-3) was held
over the tumor after gel was applied to the skin overly-
ing the tumor. A bolus injection (0.01–0.05 ml) of contrast
medium was administered into a tail vein catheter.
Six animals subcutaneously injected with the A17 cell
line and six animals injected with the BB1 cell line under-
went CEUS examination. The dynamic enhancement of the
tumor was observed in real time and continuously recorded
over a period of 180 seconds.
The curves of enhancement (time–intensity curves) of
A17 and BB1 tumors were obtained using IMAGELAB soft-
ware (Esaote) by locating an ROI over the tumors and were
analyzed based on the following parameters:
1) Maximal intensity (Mi): signal intensity of the maximal
peak of the curve in arbitrary units.
2) Slope (S): parameter automatically calculated by
Technos software, in arbitrary units based on the ratio
between Mi and time-to-peak.
3) Wash-out (Wo): percentage decrease of signal
intensity between Mi and Fi. It is quantified by means
of the following calculation: [(Mi  Fi)/Mi]  100.
4) Final intensity (Fi): signal intensity at the final time of
acquisition (185 seconds).
When the curve rose continuously after the initial up-
stroke, Mi was taken to be the signal intensity at the endpoint
of acquisition (180 seconds), whereas S and Wo were
assumed to be zero.
DCE-MRI with Gd-DTPA
With the aim of confirming the vascular differences be-
tween tumor histotypes observed by means of DCE-MRI with
macromolecular contrast agent (Gd-DTPA-albumin), two
animals per histotype group underwent DCE-MRI with
Gd-DTPA (MAGNEVIST, Schoering, Germany) as contrast
agent, within the 24 hours prior to CEUS examination. After
coronal SE and transversal multislice, fast SE T2-weighted
(RARE; TEeff = 70 milliseconds) images were acquired for
tumor localization, a dynamic series of T1-weighted, spoiled
GRE images was acquired with the following parameters:
TR = 65 milliseconds, TE = 3.8 milliseconds, a = 90j, matrix
size = 128  64 zero filled at 256  256, FOV = 5  2.5 cm2,
and space resolution = 391  391 mm2. A single slice (slice
thickness = 1.5 mm) was acquired at the tumor center. The
acquisition time for a single image was 4.1 seconds and
there was an interval of 1 second between successive
images (time resolution = 5.1). A total of 60 images was
acquired, 3 before and 57 after the contrast medium bolus
injection; Gd-DTPA at a 100-mmol/kg dosage was used. The
dynamic evolution of the signal was observed for about
5 minutes.
Histologic and Immunohistochemical Evaluation
The tumors of sacrificed mice were removed and
processed for ultrastructural and light microscopy evalua-
tion. For histology and immunohistochemistry, the tumors
were fixed in zinc fixative, dehydrated, transversally cut
in half, and embedded in paraffin wax. The two halves
were blocked and processed separately, with the cut edge
ultimately facing the microtome surface. Two consecutive
sections were taken from the face of each block and then
additional sections were taken at intervals of 100 mm as
far as roughly 1 mm into each block. Sections (5 mm)
were cut on a rotary microtome and placed on polylysine-
coated slides. The sections obtained were in planes
corresponding approximately to those utilized in MRI
and US evaluations. For histologic analysis, they were
stained using hematoxylin–eosin. Endothelial cells were
identified by immunohistochemical staining for platelet
endothelial cell adhesion molecule-1 (PECAM-1 or CD31),
using a rat monoclonal antibody directed against mouse
CD31 (Pharmingen, San Diego, CA). For immunoperoxi-
dase staining, sections were incubated in 3% hydrogen
peroxide to block endogenous peroxidase activity. To
prevent aspecific antibody binding, sections were prein-
cubated for 20 minutes in PBS, pH 7.4, containing 10%
normal rabbit serum. Next, sections were incubated over-
night at 4jC with the primary antibody directed against
CD31 (dilution of 1:100). Sections were rinsed for 15 min-
utes with PBS, followed by incubation with biotinylated
secondary antibody for 45 minutes at room temperature.
After washing with PBS, the bound antibody was visualized
by the peroxidase ABC method using diaminobenzidine
(Sigma Chemical Co., St. Louis, MO) as the developer.
The sections were rinsed with distilled water and mounted
in aqueous solutions. For the above immunohistochemical
procedures, controls were performed by replacing the
primary antibody with 10% nonimmune serum. Further
controls were made by omitting the secondary antibody.
Controls were always negative. Three samples for each
histotype underwent vessel counting at 20 magnification
in a 0.180-mm2 field. For each sample, five fields along
the longest diameter and five along the shortest diameter
of the tumor slice were chosen. Fields overlapping necrotic
areas were excluded.
Ultrastructural Analysis
For ultrastructural evaluation, part of the tumors was
fixed in 2.5% glutaraldehyde in Sorensen buffer for 2 hours,
postfixed in 1% osmium tetroxide for 1 hour, dehydrated in
graded ethanol, embedded in epon-araldite, and cut with an
Ultracut E apparatus (Reichert, Wien, Austria). The semithin
sections were stained with toluidine blue. The ultrathin
sections were stained with lead citrate and uranyl acetate
and observed with an EM10 electron microscope (Zeiss,
Oberkocken, Germany).
Statistical Analysis
MANOVA was used to evaluate the statistical significance
of the differences between A17 and BB1 tumors regarding
the following parameters:
1) kPS
2) fPV
3) vessel count
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4) vessel area
5) Mi
6) S
7) Wo.
P < .05 was accepted as statistically significant.
Results
Cell Lines and Tumors
From primary mammary tumors excised from 7– to
8-month–old transgenic mice, we established two cell lines
that exhibited different morphologic features.
The BB1 cell culture was formed of rounded cells with
typical epithelial morphology, which grew in clusters of cells
with tight junctions (Figure 1A).
The A17 culture was composed of large star- or spindle-
shaped cells forming homogeneous layers on cell culture
plates as well as on Petri dishes (Figure 1B). On prolonged
culture at confluence, the A17 cells formed foci in which
the cells grew on top of each other, a phenotype typical of
transformed cells.
When subcutaneously injected into the backs of animals,
the BB1 cells grew, after a short latency period, into tumors
that appeared as unifocal masses composed of one or
more lobes. Histologic analysis showed the features of a
lobular carcinoma as very similar to the transgenic parental
tumor. The tumor parenchyma was formed of round to poly-
gonal cells, and was rich in edema and hemorrhagic areas
(Figure 1, C and D).
The subcutaneous injection of A17 cells led to highly
invasive sarcomatoid-like tumors formed of spindle-shaped
or polygonal neoplastic cells (Figure 1E ). In A17 tumor
parenchyma, necrotic areas were not observed.
At T2-weighted MRI, A17 tumors showed more homo-
geneous and notably brighter parenchyma than BB1 tumors
Figure 1. Morphologic differences between BB1 and A17 tumor histotypes. Two different cell lines were established from mammary tumors, which had
spontaneously arisen in FVB/neuNT233 transgenic mice. The BB1 cells exhibited a round to polygonal shape, and grew in tightly junctioned clusters (A). The A17
cells were star- or spindle-shaped and grew in monolayers free of growth constraints (B). The subcutaneous injection of BB1 cells provoked lobular carcinomas
resembling spontaneous tumors (C), with large hemorrhagic areas (D), whereas A17 cells generated sarcomatoid lesions (E). At T2-weighted MRI, BB1
parenchyma showed a heterogeneous and notably lower signal intensity than A17 tumors (F and G).
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(Figure 1F ), suggesting a high cellular density and/or a high
level of hydration [27].
Vascular Analysis
The vascularity of the two different tumor histotypes was
comparatively evaluated by immunocytochemical, DCE-
MRI, and CEUS analyses. Quantitative data and their sta-
tistical significance are reported in Table 1.
Morphologic and Quantitative Analyses of Vessels
Histologic analysis of CD31-immunostained tumor slices
showed that the anatomic organization of the vasculature
was different in the two histotypes.
Considering the viable areas, the vessels of A17 tumors
(Figure 2, A and B) were, on average, significantly more nu-
merous and smaller than those in BB1 tumors (Figure 2C),
and were homogeneously spread through the tumor paren-
Table 1. Quantitative Analysis of Vascular Parameters Obtained by DCE-MRI, CEUS, and CD31 Immunostaining.
DCE-MRI CEUS CD31
Mean fPV
(ml/cm3 tissue)
Mean kPS
[(ml/min)/cm3 tissue]
Mean Mi (a.u.) Mean S (a.u.) Mean Wo (%) Mean Vessel
Count
Mean Vessel
Size (m2)
A17 0.031 ± 0.02 0.00081 ± 0.00045 0.087 ± 0.033 0.00057 ± 0.00052 13.60 ± 15.18 165.53 ± 42.04 183.82 ± 41.80
BB1 0.013 ± 0.01 0.00040 ± 0.00036 0.18 ± 0.043 0.0036 ± 0.0016 36.32 ± 24.39 79.07 ± 31.88 465.56 ± 249.11
Statistical significance P = .00001 P = .0008 P = .002 P = .002 P = .08 P f .000 P f .000
Mean values ± SD for each vascular parameter were obtained by the analyses of DCE-MRI, CEUS, and CD31 immunostaining data.
Mi and S values are expressed in arbitrary units (a.u.). In vessel count, fields overlapping necrotic areas were excluded.
The necrotic fraction represented 30% to 40% of BB1 tumors, which was undetectable in A17 tumors.
For each parameter, a comparison was made between the two histotypes and the statistical significance of any difference was reported.
P values accepted as statistically significant are in bold face.
Figure 2. Postmortem histopathologic analysis of BB1 and A17 tumor vasculature. Postmortem analysis of CD31-immunostained sections showed that A17
vasculature was composed of extremely numerous but, on average, very small vessels (A and B). The vessels of BB1 tumors proved less numerous and, on
average, larger, and were confined within the stromal compartment of viable areas (C). At ultrastructural analysis, the lumina of A17 vessels frequently appeared
flattened (D; arrow) and the endothelial cells exhibited blastic traits such as abundance of polyribosomes (E; black filled arrow). The occurrence of pinocytotic
vesicles (E; gray filled arrow) suggests that vessel lumina were functional. In contrast, at ultrastructural analysis, the vessels of BB1 tumors frequently appeared
enlarged (F), occasionally close to perivascular edemas (F; arrow) and delimited by morphologically differentiated endothelial cells (G; arrow).
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chyma. BB1 vessels, less numerous and on average larger,
proved to be confined to the stromal compartment of viable
areas. The difference in number was complementary to
differences in size, so that the total vascular volume of the
two tumor histotypes was comparable (Table 1). However,
given that a notable fraction of BB1 parenchyma was ne-
crotic, and considering the whole tumor sections, A17 tumors
proved notably more vascularized than BB1 tumors.
At ultrastructural examination, most A17 vessels showed
small lumens, often flattened by hypertrophic endothelial
cells, and exhibited evident blastic traits such as numerous
organelles, in particular free or endoplasmic reticulum–
associated polyribosomes, and a high cytoplasm/nucleus
ratio. The metabolic activity of endothelial cells and the func-
tionality of vessel lumina were confirmed by the presence of
pinocytotic vesicles near the plasmalemma of endothelial
cells (Figure 2, D and E ). The BB1 tumors’ ultrastructure
showed enlarged vessels, frequently lined by differentiated
endothelial cells (Figure 2, F and G).
Gd-DTPA-Albumin DCE-MRI Analysis
Contrast-enhanced MRI performed by injecting Gd-
DTPA-albumin was used with the aim of quantitatively eval-
uating the vascularity of A17 and BB1 tumors (Figure 3).
Following a previously published protocol [28], we analyzed
the two tumor histotypes for two vascular parameters: frac-
tional plasma volume (fPV) and endothelial transfer coeffi-
cient (kPS). fPV is measured as the signal intensity increase
immediately after contrast agent injection. The parenchyma
of the A17 tumors showed a significantly higher fPV than the
BB1 tumors (Figure 3C and Table 1).
The kPS parameter is calculated based on the kinetic
increase of signal intensity after contrast agent injection and
is a measure of transendothelial permeability. It proved
significantly higher in the A17 tumors than in BB1 tumors
(Figure 3C and Table 1).
Figure 3. In vivo assessment of BB1 and A17 tumor vasculature by DCE-MRI with Gd-DTPA-albumin. A series of quadrangular ROIs matching the whole tumor
section was manually selected on the MRI images (A), and was analyzed as previously described [20] to measure the fractional vascular volume (fPV) and
transendothelial permeability (kPS) of tumor vessels. The first parameter is dependent on the intercept between the curve and the y-axis; the latter depends on the
slope of the curve (B). Both parameters proved significantly higher, on average, in A17 than in BB1 tumors (C; see also Table 1).
Figure 4. In vivo assessment of BB1 and A17 tumor vasculature by DCE-MRI
with Gd-DTPA. DCE-MRI with Gd-DTPA as contrast agent confirmed that
A17 tumors showed a higher level of vascularization than BB1 tumors. Unlike
DCE-MRI with Gd-DTPA-albumin, the maps of enhancement obtained by
pixel-by-pixel subtraction between the last postcontrast and the precontrast
images make evident the difference in size and the distribution of vessel
network between A17 (A) and BB1 (B) tumors. Two representative time–
intensity curves show vascular differences observed between the two tumor
histotypes (C).
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Gd-DTPA DCE-MRI Analysis
Two mice per histologic group underwent DCE-MRI ex-
amination with Gd-DTPA as the contrast agent (Figure 4).
As expected, the curves of enhancement of A17 tumors
followed a signal intensity value scale, which was notably
higher than that of BB1 tumors (Figure 4C).
CEUS
DCE ultrasound performed using SonoVue microbubbles
as the contrast agent proved apparently inconsistent with
DCE-MRI observations (Figure 5). The Mi and S values of
BB1 tumors were, on average, significantly higher than those
of A17 tumors. Time–intensity curves of BB1 tumors had a
mean Wo that was almost three times higher than those of
A17 tumors, and two cases of A17 curves showed a contin-
uous time increase in signal intensity. However, at statistical
analysis, the Wo values of BB1 and A17 tumors were not
significantly (P < .08) different (Figure 5C and Table 1).
Discussion
Our data demonstrate that particular histologic features
can lead to a mismatch between DCE-MRI and CEUS.
DCE-MRI, as well as immunohistochemical analysis, showed
that carcinosarcomatoid lesions (A17 tumors) were richer
in vessels than carcinomas (BB1 tumors), but the first
histologic type of tumor exhibited a significantly higher resis-
tance to microbubble flow and a time–intensity dynamic
characterized by lower Mi, delayed S, and reduced Wo.
The histologic and ultrastructural analysis of tumor samples
provided a reasonable explanation for this mismatch. In ac-
cordance with MRI-based measurements of vascular param-
eters, A17 tumors had a notably large number of vessels
homogeneously spread within tumor parenchyma, but their
lumina often appeared to have diameters on the order of a few
micrometers, and many of them seemed to have collapsed
under the pressure exerted by the surrounding high cellular
density. It has recently been demonstrated that solid stress
generated by tumor cells growing in a confined space com-
presses blood vessels and increases microvascular pressure
(MVP) and interstitial fluid pressure (IFP),whereas reduction in
cell density caused by drug-induced apoptosis can decom-
press vessels and restore normal blood flow [10]. BB1 tumor
parenchyma showed an evident abundance of large and
small necrotic areas, which probably keep solid stress levels
low and allow vessels to remain open.
Figure 5. In vivo assessment of BB1 and A17 tumor vasculature by CEUS with SonoVue contrast agent. CEUS showed that A17 tumors had a lower level of
vascularization than BB1 tumors. Signal enhancement after contrast agent injection was less evident in A17 (A, I: precontrast; II: postcontrast) than in BB1 (A, III:
precontrast; IV: postcontrast) tumors. Two representative time– intensity curves show differences between time course contrast enhancement observed in A17
(B, top panel) and BB1 (B, bottom panel) tumors. BB1 tumors had a reduced maximal intensity peak (Mi), delayed slope (S), and reduced wash-out (Wo) in
comparison with BB1 tumors (C; see also Table 1).
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The high transendothelial permeability (kPS) of A17 ves-
sels could also contribute to solid stress exerted by tumor
parenchyma on vessels. An enhanced fluid exchange across
leaky endothelial walls can shift the hydrostatic equilibrium
between the microvascular and interstitial space toward a
state of interstitial hypertension.
In normal tissue, extravasation of fluid from the vessel
bed is tightly regulated due to the low hydraulic conductivity
and the highly specialized selectivity of vascular walls. The
small amount of any extravasated fluid is readily drained by
lymphatic vessels. Under these conditions, the hydrostatic
pressure gradient between the vascular and interstitial
compartments is kept stable and, hence, the IFP is close
to zero. Enhanced transendothelial permeability, in the
absence of a functioning lymphatic system, may cause a
potential coupling between vascular and interstitial fluid
flow, which in turn leads to peritumoral edema and IFP
enhancement [11,12,29].
A high density of newly sprouted, small-sized, leaky,
morphologically immature vessels in tumors can be the
consequence of intense neoangiogenesis. Continuous and
vigorous stimulus to the proliferation of endothelial cells in
tumors, estimated to be 50 to 200 times greater than that of
endothelial cells in normal tissue [30,31], is frequently not
supported by a coordinated maturation program [32] and has
been reported to be associated with poor prognosis [33].
In our study, A17 vessels showed blastic traits that were
typical of newly formed vessels. They appeared less mature,
as well as more numerous and homogeneously distributed
than BB1 vessels, which exhibited a notably large mean
diameter reported to be typical of carcinomas [34].
However, resistance to microbubble flow is not necessar-
ily a sign of poorly functional vascularization. Their notable
growth rate, high invasive potential, absence of necrotic
areas, and frequent occurrence of pinocytotic vesicles in
the cytoplasm of endothelial cells all suggested that A17
tumors were endowed with an efficient vascular system.
Small-sized or flattened vessels might trap or break air
microbubbles, but still be functional for the flow of erythro-
cytes, which have high deformability and resistance to
pressure. This may explain their refractoriness to wash-in
(delayed S and low Mi) and their reduced wash-out. How-
ever, it is possible that a portion of A17 tumor microcircula-
tion could be functionally impervious to microbubbles as well
as erythrocytes. It is known that in physiological conditions, a
small proportion of functionally opened capillaries provides
sufficient blood perfusion for the needs of tissues, whereas
blood hyperflow could even be harmful.
In our experimental model, the mismatch between CEUS
and DCE-MRI time course parameters was observed in
carcinosarcomatoid lesions provoked by the subcutaneous
injection of mesenchymal-like cells of mammary origin. Thus,
in mammary tumor analysis, this mismatch could give rise
to suspicious epithelial–mesenchymal transition [35].
Taken together, these observations demonstrate that
CEUS alone could induce incorrect diagnoses when tumors
have particular morphologic features such as small, col-
lapsed vessels, but integrated analysis using CEUS and
DCE-MRI makes it possible to identify in vivo tumors char-
acterized by numerous but phenotypically immature vessels:
a typical consequence of an intense neoangiogenesis.
Further investigations are needed to compare the infor-
mative potential of CEUS with that of other in vivomethods of
vascular analysis. An interesting insight would be to verify
whether the tumor size can affect CEUS- and MRI-based
diagnosis. In the present work, we employed 10- to 15-mm
specimens—consistent with the fact that, in breast cancer,
diagnostic problem arises in the size of such nodules. Yet, as
the tumor size enlarges, necrotic areas and vascular col-
lapse might change and the CEUS and MRI analyses might
be differently affected.
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